Published in J Interv Card Electrophysiol on May 09, 2015
Five years of keeping a watch on the left atrial appendage-how has the WATCHMAN fared? J Thorac Dis (2016) 0.75
Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol (2012) 3.12
Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation (2010) 2.56
Left atrial appendage: structure, function, and role in thromboembolism. Heart (1999) 2.52
Patterns of initiation of oral anticoagulants in patients with atrial fibrillation- quality and cost implications. Am J Med (2014) 2.27
National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med (2004) 1.92
Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm (2010) 1.89
Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol (2013) 1.50
Hyponatremia following mild/moderate subarachnoid hemorrhage is due to SIAD and glucocorticoid deficiency and not cerebral salt wasting. J Clin Endocrinol Metab (2013) 1.46
Natriuretic peptide metabolism, clearance and degradation. FEBS J (2011) 1.29
Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res (1996) 1.15
The effects of LAA ligation on LAA electrical activity. Heart Rhythm (2014) 1.08
Thiazide induces water absorption in the inner medullary collecting duct of normal and Brattleboro rats. Am J Physiol (1999) 1.02
Localized reentry within the left atrial appendage: arrhythmogenic role in patients undergoing ablation of persistent atrial fibrillation. Heart Rhythm (2011) 0.97
Roles of atrial natriuretic peptide and its therapeutic use. J Cardiol (2010) 0.97
Effect of the maze procedure for atrial fibrillation on atrial and brain natriuretic peptide. Am J Cardiol (1997) 0.85
Atrial natriuretic peptide secretion and body fluid balance after bilateral atrial appendectomy by the maze procedure. J Thorac Cardiovasc Surg (1998) 0.84
Relationship between left atrial appendage function and plasma concentration of atrial natriuretic peptide. Eur J Echocardiogr (2000) 0.81
Left atrial appendage exclusion-Where do we stand? J Thorac Dis (2014) 0.80
Impact of left atrial appendage exclusion on left atrial function. J Thorac Cardiovasc Surg (2007) 0.76
Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med (2007) 6.68
Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation (2012) 4.56
Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation (2010) 3.42
Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res (2004) 2.50
Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res (2008) 2.31
Effect of aspirin on late preconditioning against myocardial stunning in conscious rabbits. J Am Coll Cardiol (2003) 2.23
Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J (2003) 2.22
Utility of dexmedetomidine in sedation for radiofrequency ablation of atrial fibrillation. J Perianesth Nurs (2013) 1.98
Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc Res (2002) 1.90
A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the upregulation of cardioprotective proteins by ischemic preconditioning. J Mol Cell Cardiol (2011) 1.79
Effect of yoga on arrhythmia burden, anxiety, depression, and quality of life in paroxysmal atrial fibrillation: the YOGA My Heart Study. J Am Coll Cardiol (2013) 1.77
Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience. Circ Arrhythm Electrophysiol (2014) 1.64
The role of TNF-alpha receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning. J Mol Cell Cardiol (2008) 1.61
Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol (2004) 1.56
Transseptal access and atrial fibrillation ablation guided by intracardiac echocardiography in patients with atrial septal closure devices. Heart Rhythm (2011) 1.52
Measuring the quality of echocardiography using the predictive value of the left ventricular ejection fraction. J Am Soc Echocardiogr (2013) 1.46
Mechanism of cyclooxygenase-2 upregulation in late preconditioning. J Mol Cell Cardiol (2003) 1.45
Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure. Cardiovasc Res (2010) 1.45
Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol (2011) 1.40
Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats. Basic Res Cardiol (2006) 1.32
Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice. Circ Res (2009) 1.32
Bone marrow-derived pluripotent very small embryonic-like stem cells (VSELs) are mobilized after acute myocardial infarction. J Mol Cell Cardiol (2008) 1.28
Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure. Circ Arrhythm Electrophysiol (2010) 1.27
FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy. Am J Physiol Endocrinol Metab (2013) 1.26
Morphological characterization of very small embryonic-like stem cells (VSELs) by ImageStream system analysis. J Cell Mol Med (2007) 1.26
Transplantation of expanded bone marrow-derived very small embryonic-like stem cells (VSEL-SCs) improves left ventricular function and remodelling after myocardial infarction. J Cell Mol Med (2010) 1.25
Paging "Dr. Google": does technology fill the gap created by the prenatal care visit structure? Qualitative focus group study with pregnant women. J Med Internet Res (2014) 1.23
Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc Med (2003) 1.20
Noncanonical Wnt11 signaling is sufficient to induce cardiomyogenic differentiation in unfractionated bone marrow mononuclear cells. Circulation (2008) 1.17
Radiofrequency ablation of premature ventricular ectopy improves the efficacy of cardiac resynchronization therapy in nonresponders. J Am Coll Cardiol (2012) 1.16
Gene transfer of inducible nitric oxide synthase affords cardioprotection by upregulating heme oxygenase-1 via a nuclear factor-{kappa}B-dependent pathway. Circulation (2009) 1.15
Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway. Circulation (2007) 1.15
Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J (2008) 1.15
Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions <45 min. Am J Physiol Heart Circ Physiol (2006) 1.13
Relationship between complex fractionated electrograms (CFE) and dominant frequency (DF) sites and prospective assessment of adding DF-guided ablation to pulmonary vein isolation in persistent atrial fibrillation (AF). J Cardiovasc Electrophysiol (2011) 1.12
Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol (2004) 1.12
IntraCameral right coronary artery: detection by 64 slice coronary computed tomographic angiography and implications for radiofrequency ablation of atrial dysrhythmias. Pacing Clin Electrophysiol (2007) 1.11
Pulmonary vein stenosis due to a compressive malignant tumor detected by transesophageal echocardiography. Circulation (2011) 1.11
Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences. Am J Physiol Heart Circ Physiol (2005) 1.09
Ejection fraction may improve but the scar still exists! The risk may be lower but not zero. J Am Coll Cardiol (2014) 1.07
Hypercholesterolemia abrogates late preconditioning via a tetrahydrobiopterin-dependent mechanism in conscious rabbits. Circulation (2005) 1.06
Pulmonary vein total occlusion following catheter ablation for atrial fibrillation: clinical implications after long-term follow-up. J Am Coll Cardiol (2006) 1.06
Differences in experience with a new delivery device for LAA ligation among various U.S. centers. J Am Coll Cardiol (2015) 1.04
Expanding multi-disciplinary approaches to healthcare information technologies: what does information systems offer medical informatics? Int J Med Inform (2007) 1.03
The late phase of preconditioning and its natural clinical application--gene therapy. Heart Fail Rev (2007) 1.02
Delayed adaptation of the heart to stress: late preconditioning. Stroke (2004) 1.01
HO-1 induction by HIF-1: a new mechanism for delayed cardioprotection? Am J Physiol Heart Circ Physiol (2005) 1.00
Recurrent unilateral pleural effusion in a hypertrophic cardiomyopathy patient secondary to atrial arrhythmias and the role of radiofrequency ablation. Europace (2012) 1.00
Atrial fibrillation ablation in patients with gastroesophageal reflux disease or irritable bowel syndrome-the heart to gut connection! J Interv Card Electrophysiol (2013) 0.98
Atrial fibrillation and the risk of incident dementia: a meta-analysis. Heart Rhythm (2012) 0.98
Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium. J Mol Cell Cardiol (2011) 0.97
Noncanonical Wnt11 signaling and cardiomyogenic differentiation. Trends Cardiovasc Med (2008) 0.96
Radiofrequency ablation of atrial fibrillation in patients with mitral or aortic mechanical prosthetic valves: a feasibility, safety, and efficacy study. Heart Rhythm (2011) 0.94
The usefulness of information and communication technologies in crisis response. AMIA Annu Symp Proc (2008) 0.94
Catheter ablation of ventricular fibrillation storm in patients with infiltrative amyloidosis of the heart. J Cardiovasc Electrophysiol (2006) 0.93
Risk factors for coronary heart disease in Indians: a case-control study from Eastern India. Indian Heart J (2006) 0.93
Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond. Basic Res Cardiol (2011) 0.91
No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis. Int J Cardiol (2012) 0.91
TGF-beta1 enhances cardiomyogenic differentiation of skeletal muscle-derived adult primitive cells. Basic Res Cardiol (2008) 0.90
Impact of nonfluoroscopic MediGuide™ tracking system on radiation exposure in radiofrequency ablation procedures (LESS-RADS registry)-an initial experience. J Interv Card Electrophysiol (2013) 0.90
The role of percutaneous left ventricular assist devices during ventricular tachycardia ablation. Europace (2012) 0.89
Differences in treatment and in outcomes between idiopathic and secondary forms of organizing pneumonia. Am J Ther (2007) 0.89
Congenital ostial left main coronary artery stenosis associated with a bicuspid aortic valve in a young woman. J Invasive Cardiol (2006) 0.89
Sca-1 expression is associated with decreased cardiomyogenic differentiation potential of skeletal muscle-derived adult primitive cells. J Mol Cell Cardiol (2006) 0.88
End-stage renal disease is associated with worse outcomes in hospitalized patients with peptic ulcer bleeding. Gastrointest Endosc (2013) 0.87
Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: safety and feasibility. Heart Rhythm (2010) 0.87
Efficacy of a weight-loss website based on positive deviance. A randomized trial. Am J Prev Med (2011) 0.86
Mapping and ablation of ventricular arrhythmias with magnetic navigation: comparison between 4- and 8-mm catheter tips. J Interv Card Electrophysiol (2009) 0.85
Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study. Heart Rhythm (2012) 0.84
Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences. Basic Res Cardiol (2011) 0.84
Impact of valvular calcification on the diagnostic accuracy of transesophageal echocardiography for the detection of congenital aortic valve malformation. Echocardiography (2007) 0.84
Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction. PLoS One (2011) 0.84
Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences. Basic Res Cardiol (2011) 0.84
Cardiac progenitor cells: the revolution continues. Circ Res (2005) 0.83
Role of yoga as an adjunctive therapy in patients with neurocardiogenic syncope: a pilot study. J Interv Card Electrophysiol (2015) 0.83
Pacemaker utilization during permanent atrial fibrillation in patients who received pacemaker implantation for sinus node dysfunction. Am J Cardiol (2005) 0.82
Atrial arrhythmias after surgical maze: findings during catheter ablation. J Am Coll Cardiol (2006) 0.82
Comparison of risk prediction scoring systems for ward patients: a retrospective nested case-control study. Crit Care (2014) 0.82
Very small embryonic-like stem cells: biology and therapeutic potential for heart repair. Antioxid Redox Signal (2011) 0.82